Adenoviral-mediated interferon-gamma gene therapy augments pulmonary host defense of ethanol-treated rats (Q45886066)

17 December 2017

title

Adenoviral-mediated interferon-gamma gene therapy augments pulmonary host defense of ethanol-treated rats (English)

1 reference

17 December 2017

0 references

1 reference

8

Summer WR

1 reference

17 December 2017

Judd E Shellito

9

object named as

Shellito JE

1 reference

17 December 2017

author name string

Kolls JK

1

1 reference

17 December 2017

Lei D

2

1 reference

17 December 2017

Stoltz D

3

1 reference

17 December 2017

Zhang P

4

1 reference

17 December 2017

Schwarzenberger PO

5

1 reference

17 December 2017

Ye P

6

1 reference

17 December 2017

Bagby G

7

1 reference

17 December 2017

Nelson S

10

1 reference

17 December 2017

publication date

1 February 1998

1 reference

17 December 2017

Alcoholism: Clinical and Experimental Research

published in

1 reference

17 December 2017

volume

22

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

157-162

1 reference

17 December 2017

Recurrent pneumonia. Predisposing illness and clinical patterns in 158 patients

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03632.X

Prevention of respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03632.X

Macrophages and polymorphonuclear neutrophils in lung defense and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03632.X

Colony-stimulating factors and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03632.X

Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03632.X

Activation of human macrophages. Comparison of other cytokines with interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03632.X

Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03632.X

Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03632.X

Interferon-gamma, the activated macrophage, and host defense against microbial challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03632.X

Resistance to Mycoplasma pulmonis mediated by activated natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03632.X

Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03632.X

Interferon-gamma in the management of infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03632.X

Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03632.X

Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03632.X

10.1111/J.1530-0277.1998.TB03632.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

9514301

1 reference

17 December 2017